Financial Comparison

Johnson & Johnson vs Pfizer Inc

Click a ticker to view the full analysis.

JNJ vs

In short

Johnson & Johnson is the more profitable of the two, keeping 28.5% of revenue as net profit against 12.4% for Pfizer Inc. Pfizer Inc trades at the higher trailing P/E (44.7× vs 39.1× for Johnson & Johnson), so investors pay more for each dollar of its earnings. Fisclear flags 1 medium- or high-severity risk for Johnson & Johnson and 1 for Pfizer Inc.

Based on filings for periods ending 27 Sept 2026 (JNJ) and 27 Sept 2026 (PFE) · Updated

FisclearScore Comparison

JNJ64Fair
PFE59Fair
Quality+25
78
53
Efficiency+5
50
55
Value+10
52
62
Cashflow+3
77
80
Regime
55
55
Peers+18
68
50

FisclearScore is a quantitative model. JNJ shown solid · PFE shown dashed. Not financial advice.

MetricJNJPFE
Price$257.78$31.27
Market Cap$621.2B$178.2B
P/E (TTM)39.1x44.7x
P/B7.3x2.1x
Beta0.210.30
Div Yield2.07%5.59%
Revenue (TTM)$94.2B$62.6B
Net Income$26.8B$7.8B
Gross Margin67.9%—
Risk Flags1 flag2 flags

Related comparisons

Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.